# Avidia Bancorp, Inc.: overview AVBC · NYSE · CIK 2058758 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/avbc.md) · [Financials](/companies/avbc/financials.md) · [Filings](/companies/avbc/filings.md) · [Insiders](/companies/avbc/insiders.md) Revenue is not reported in this company’s XBRL financial statements. ## Last eight quarters | Line item | Unit | period not labelled (2024-09-30) | period not labelled (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Net margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Diluted EPS | $ per share | not reported | not reported | not reported | not reported | [(0.05)](/filings/0001193125-25-283184.md) | not reported | [0.32](/filings/0001193125-26-224283.md) | [0.39](/filings/0001193125-26-349298.md) | | Free cash flow | $m | [1.6 d](/filings/0001193125-25-283184.md) | [19.2 d](/filings/0001193125-26-129221.md) | [(3.9)](/filings/0001193125-26-224283.md) | [(3.3) d](/filings/0001193125-26-349298.md) | [23.3 d](/filings/0001193125-25-283184.md) | [8.0 d](/filings/0001193125-26-129221.md) | [7.7](/filings/0001193125-26-224283.md) | [9.2 d](/filings/0001193125-26-349298.md) | - Revenue. XBRL not reported. - Gross margin (gross profit / revenue). XBRL not reported. - Operating margin (operating income / revenue). XBRL not reported. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss. Derived values: 12-month figure less the 9-month figure. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure. ## Last five fiscal years | Line item | Unit | FY (2024-12-31) | FY2025 (2025-12-31) | | --- | --- | ---: | ---: | | Revenue | $m | not reported | not reported | | Gross margin | % | not reported | not reported | | Operating margin | % | not reported | not reported | | Net margin | % | not reported | not reported | | Diluted EPS | $ per share | not reported | [(0.18)](/filings/0001193125-26-129221.md) | | Free cash flow | $m | [20.4](/filings/0001193125-26-129221.md) | [24.1](/filings/0001193125-26-129221.md) | - Revenue. XBRL not reported. - Gross margin (gross profit / revenue). XBRL not reported. - Operating margin (operating income / revenue). XBRL not reported. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/avbc/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $24.2m | 1,151,670 | | Added +875,156 | | [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $16.8m | 800,793 | | Reduced −21,183 | | [FJ Capital Management LLC](/funds/1599170.md) | 2026-06-30 | $10.4m | 497,258 | | Unchanged | | [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $9.3m | 442,624 | | Added +222,719 | | [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $5.3m | 251,299 | | Added +188,377 | | [TWO SIGMA INVESTMENTS, LP](/funds/1179392.md) | 2026-06-30 | $5.2m | 247,210 | | Added +36,088 | | [HENNESSY ADVISORS INC](/funds/1145255.md) | 2026-06-30 | $3.3m | 157,000 | | Added +2,000 | | [MORGAN STANLEY](/funds/895421.md) | 2026-06-30 | $3.1m | 149,088 | | Added +25,163 | | [MARSHALL WACE, LLP](/funds/1318757.md) | 2026-06-30 | $3.1m | 146,200 | | Added +45,218 | | [NORTHERN TRUST CORP](/funds/73124.md) | 2026-06-30 | $3.0m | 143,822 | | Added +103,632 | ## Recent filings [All 158 filings](/companies/avbc/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-10-23 | 16:36 ET | [8-K](/filings/0001193125-26-430532.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-430532 | | 2026-09-16 | 20:45 ET | [8-K/A](/filings/0001193125-26-393166.md) | 5.07 Shareholder vote results | 0001193125-26-393166 | | 2026-09-15 | 20:40 ET | [8-K](/filings/0001193125-26-392010.md) | 5.07 Shareholder vote results | 0001193125-26-392010 | | 2026-08-13 | 20:30 ET | [10-Q](/filings/0001193125-26-349298.md) | Quarterly report, period 2026-06-30 | 0001193125-26-349298 | | 2026-08-07 | 20:34 ET | [DEF 14A](/filings/0001193125-26-340379.md) | Proxy statement, period 2026-09-15 | 0001193125-26-340379 | | 2026-08-04 | 20:42 ET | [8-K](/filings/0001193125-26-333001.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-333001 | | 2026-07-27 | 20:36 ET | [8-K](/filings/0001193125-26-318176.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-318176 | | 2026-06-26 | 20:31 ET | [8-K](/filings/0001193125-26-285577.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-285577 | | 2026-05-28 | 20:32 ET | [8-K](/filings/0001193125-26-245337.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-245337 | | 2026-05-14 | 21:01 ET | [10-Q](/filings/0001193125-26-224283.md) | Quarterly report, period 2026-03-31 | 0001193125-26-224283 | ## Latest annual report [Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001193125-26-129221.md), filed Mar 27, 2026. ## Forecast league Not in this season’s league. [This season’s league](/leagues.md) ## About the filer - CIK: 2058758 - Tickers: AVBC - Exchange: NYSE - SIC code: 6036 Savings Institutions, Not Federally Chartered - State of incorporation: not reported - Filer category:
Emerging growth company Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:50 ET. No prices; not investment advice.